Pliant Therapeutics Inc (PLRX)

May 21, 2025

Pliant Therapeutics presents new fibrosis treatment data By Investing.com - Investing.com Canada

May 21, 2025

May 21, 2025

Pliant Therapeutics Presents Clinical and Preclinical Data at th - GuruFocus

May 21, 2025

May 21, 2025

Pliant Therapeutics presents new fibrosis treatment data - Investing.com

May 21, 2025

May 21, 2025

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference | PLRX Stock News - GuruFocus

May 21, 2025

May 21, 2025

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society ... - Eagle-Tribune

May 21, 2025

May 21, 2025

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference - GlobeNewswire

May 21, 2025

May 21, 2025

Breakthrough: Pliant's New Lung Disease Drug Outperforms Standard Treatment in Latest Clinical Data - Stock Titan

May 21, 2025

May 14, 2025

How Are Things Looking For Pliant Therapeutics Inc (NASDAQ: PLRX) For The Short Term? - Stocksregister

May 14, 2025

May 12, 2025

Cautious Hold Rating on Pliant Therapeutics Amid Clinical and Financial Uncertainties - TipRanks

May 12, 2025

May 09, 2025

Another Bay Area biotech company announces layoffs - MSN

May 09, 2025

May 09, 2025

Pliant Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025

May 08, 2025

Pliant (PLRX) Prepares to Release Topline Results from BEACON-IP - GuruFocus

May 08, 2025

May 08, 2025

Pliant (PLRX) Prepares to Release Topline Results from BEACON-IPF Trial | PLRX Stock News - GuruFocus

May 08, 2025

May 08, 2025

Pliant Therapeutics reports Q1 EPS (92c), consensus (62c) - TipRanks

May 08, 2025

May 08, 2025

Pliant Therapeutics (PLRX) Advances in Clinical Trials and Oncology Research | PLRX Stock News - GuruFocus

May 08, 2025

May 08, 2025

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewswire

May 08, 2025

May 07, 2025

Market Watch Highlights: Pliant Therapeutics Inc (PLRX) Ends on an Downturn Note at 1.43 - DWinneX

May 07, 2025

May 05, 2025

Pliant Therapeutics Cuts Workforce by Nearly Half - Powder & Bulk Solids

May 05, 2025

May 02, 2025

Bay Area biotech company Pliant Therapeutics slashes staff after losing $655 million in value - MSN

May 02, 2025

May 02, 2025

Pliant cuts workforce by 45% following lung trial termination - Clinical Trials Arena

May 02, 2025

May 02, 2025

Pliant Therapeutics to cut 45% of workforce (PLRX:NASDAQ) - Seeking Alpha

May 02, 2025

May 01, 2025

Pliant Therapeutics (PLRX) Restructures to Prolong Financial Res - GuruFocus

May 01, 2025

May 01, 2025

Pliant Therapeutics Reduces Workforce as Part of Strategic Realignment - MarketWatch

May 01, 2025

May 01, 2025

Pliant Therapeutics (PLRX) Restructures to Prolong Financial Resources | PLRX Stock News - GuruFocus

May 01, 2025

May 01, 2025

Pliant Therapeutics announces workforce reduction By Investing.com - Investing.com India

May 01, 2025

May 01, 2025

Pliant Therapeutics announces workforce reduction - Investing.com

May 01, 2025

May 01, 2025

Pliant Therapeutics Announces Major Workforce Reduction - TipRanks

May 01, 2025

May 01, 2025

Pliant Therapeutics Announces Workforce Reduction and Cost Saving Initiatives to Support Late-Stage Clinical Trials - Nasdaq

May 01, 2025

May 01, 2025

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations - GlobeNewswire

May 01, 2025

May 01, 2025

Pliant Therapeutics Slashes Nearly Half its Workforce While Awaiting Crucial IPF Drug Results - Stock Titan

May 01, 2025

May 01, 2025

You might want to take a look at Pliant Therapeutics Inc (PLRX) now - Sete News

May 01, 2025

Apr 30, 2025

Pliant Therapeutics Inc [PLRX] stock was sold by Coulie Bernard at the price of US$0.59 million - knoxdaily.com

Apr 30, 2025

Apr 30, 2025

Market Momentum: Pliant Therapeutics Inc (PLRX) Registers a 0.68 Increase, Closing at 1.48 - DWinneX

Apr 30, 2025

Apr 30, 2025

Stock Performance Spotlight: Cg Oncology Inc (CGON) Ends the Day at 26.94, Down by -3.68 - DWinneX

Apr 30, 2025

Apr 30, 2025

Pliant Therapeutics Inc (PLRX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com

Apr 30, 2025

Apr 29, 2025

Legal & General Group Plc Grows Stock Holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Defense World

Apr 29, 2025

Apr 28, 2025

Pliant Therapeutics Inc: A Year of Highs, Lows, and Market Resilience - investchronicle.com

Apr 28, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 26, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc.PLRX - Louisiana First News

Apr 26, 2025

Apr 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant ... - Bluefield Daily Telegraph

Apr 25, 2025

Apr 25, 2025

Pliant Therapeutics discovers new integrin αvβ1, αvβ6 and/or αvβ8 antagonists - BioWorld MedTech

Apr 25, 2025

Apr 25, 2025

Pliant Therapeutics Inc’s Market Journey: Closing Weak at 3.03, Down -1.62 - DWinneX

Apr 25, 2025

Apr 24, 2025

PLRXPliant Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 24, 2025

Healthy Upside Potential: Pliant Therapeutics Inc (PLRX) - Sete News

Apr 24, 2025

Apr 24, 2025

Market Recap Check: Pliant Therapeutics Inc (PLRX)’s Positive Finish at 1.54, Up/Down 2.67 - DWinneX

Apr 24, 2025

Apr 23, 2025

Pliant Therapeutics Inc (PLRX)’s stock price in review: A technical analysis - uspostnews.com

Apr 23, 2025

Apr 23, 2025

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Shares Bought by JPMorgan Chase & Co. - Defense World

Apr 23, 2025